Hanna Cancer Associates - University of Tennessee

Knoxville, Tennessee 37920

0 studies enrolling now · 2 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) — Completed